Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years.

Breast cancer research : BCR - 29 Sept 2020

Brentnall Adam R, Warren Ruth, Harkness Elaine F, Astley Susan M, Wiseman Julia, Fox Jill, Fox Lynne, Eriksson Mikael, Hall Per, Cuzick Jack, Evans D Gareth, Howell Anthony

Abstract excerpt

BACKGROUND: A decrease in breast density due to tamoxifen preventive therapy might indicate greater benefit from the drug. It is not known whether mammographic density continues to decline after 1 year of therapy, or whether measures of breast density change are sufficiently stable for personalised recommendations. METHODS: Mammographic density was measured annually over up to 5 years in premenopausal women with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Breast Density

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Cohort Studies

Share to Mammography

Share to Premenopause

Share to Tamoxifen

Share to Women's Health

Source

Open in PubMed Open full text

Identifiers

PMID: 32993747
DOI: 10.1186/s13058-020-01340-4
PMCID: PMC7523310

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years.PMID 32993747Read ↗

Longitudinal history of mammographic breast density and breast cancer risk by familial risk, menopausal status, and initial mammographic density level in a high risk cohort: a nested case-control study.Semantic proximity Read ↗

Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment.Semantic proximity Read ↗

Mammographic breast density and breast cancer risk by menopausal status, postmenopausal hormone use and a family history of breast cancer.Semantic proximity Read ↗

Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects.Semantic proximity Read ↗

Impact of systemic adjuvant therapy and CYP2D6 activity on mammographic density in a cohort of tamoxifen-treated breast cancer patients.Semantic proximity Read ↗

Mammographic density as a risk factor for breast cancer in a German case-control study.Semantic proximity Read ↗

The Problem of Mammographic Breast Density - The Position of the DEGUM Working Group on Breast Ultrasound.Semantic proximity Read ↗

Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study.Semantic proximity Read ↗

Cyclic endogenous estrogen and progesterone vary by mammographic density phenotypes in premenopausal women.Semantic proximity Read ↗

Mammographic density phenotypes and risk of breast cancer: a meta-analysis.Semantic proximity Read ↗

Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Reduced mammographic density with use of a gonadotropin-releasing hormone agonist-based chemoprevention regimen in BRCA1 carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.